Click me

Merck (MRK) Earnings Review

EARNINGS REVIEW 3QFY13 Analysts Expectations vs. Actual Results Singulairs continued decline Revenue Miss in sales lead the the revenues to Actual I Analyst Estimates miss estimates for $11.13 the quarter $11.03 EPS beat estimates due to expanding margins, which were caused by the the cost cutting measures. Net Revenues Analysts had estimated earnings of $0.874 per share for the third quarter of 2013, which Merck beat with reported EPS of $0.92 SOURCES: Company Data, SEC filings, Bloomberg Professional Services BIDNESS Etc. DISCLAIMER: Bidness Etc(TM) and related marks are owned by Bidness Etc. Any other trademarks appearing on this website are the property of their respective owners, and are not used to indicate the origin of goods or services offered or provided by Bidness Etc herein or to suggest approval for or affiliation with Bidness Etc. $ billions

Merck (MRK) Earnings Review

shared by bidnessetc on Dec 11
The most recent earnings reported by Merck were for 3QFY13. The company’s performance did not live up to analysts’ estimates. The company reported a revenue miss and also an EPS miss. The problems...


Did you work on this visual? Claim credit!

Get a Quote

Embed Code

For hosted site:

Click the code to copy


Click the code to copy
Customize size